SCHEMBL3785977

SCHEMBL3785977

O=C1C=C(c2cn(-c3cccc(-c4ccsc4)c3)c3ccccc23)C(=O)N1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
PRKCA P17252 4/20 0.35
PRKCB P05771 3/20 0.35
GSK3B P49841 2/20 0.35
STK10 O94804 1/20 0.35
SLK Q9H2G2 1/20 0.35
PTPRC P08575 1/20 0.34
KDR P35968 4/20 0.33
PRKD3 O94806 2/20 0.33
PRKCG P05129 2/20 0.33
PRKCH P24723 2/20 0.33
PRKCI P41743 2/20 0.33
PRKCE Q02156 2/20 0.33
PRKCQ Q04759 2/20 0.33
PRKCZ Q05513 2/20 0.33
PRKCD Q05655 2/20 0.33
PRKD1 Q15139 2/20 0.33
PRKDC P78527 1/20 0.33
GLO1 Q04760 1/20 0.32
FLT1 P17948 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3600677 0.80 KDM4E (0.46) PRKCAPRKCBGSK3BPTPRCPRKD3
SCHEMBL1127976 0.74 GSK3B (0.56) PRKCAPRKCBGSK3BPRKCGPRKCZ
SCHEMBL6344247 0.73 MGLL (0.44) ALOX5PTPRCKDRPRKDCGLO1
SCHEMBL5758398 0.70 PRKCA (0.74) PRKCAPRKCBGSK3BKDRPRKCG
SCHEMBL6344338 0.69 GSK3B (0.41) PRKCAPRKCBGSK3BPTPRCPRKCG
SCHEMBL4848432 0.68 CDK2 (0.39) PRKCAPRKCBGSK3BPRKCGCAMK2D
SCHEMBL5879232 0.67 CCNE2 (0.63) PRKCAGSK3BPTPRC
SCHEMBL29504831 0.67 CCNE2 (0.63) PRKCAGSK3BPTPRC
SCHEMBL2954257 0.67 GSK3B (0.43) PRKCAPRKCBGSK3BPTPRCPRKD3
Hydrochloric Acid SCHEMBL29664072 0.66 CCNE2 (0.61) PRKCAGSK3BPTPRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855203-B2 Indazolyl-substituted pyrroline compounds as kinase inhibitors ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. (US) 2010-12-21 US disclosed
US-20080096949-A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096949-A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors MAP2K2, MAP3K20, MAP2K3 ALOX5 4672/4885PRKCA 43/4885PRKCB 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.